financetom
Business
financetom
/
Business
/
Why Cloud-Based Software Company Braze Shares Are Diving Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Cloud-Based Software Company Braze Shares Are Diving Today
Mar 28, 2024 10:54 AM

Braze, Inc. ( BRZE ) (BRZE) shares are trading lower after the company issued soft EPS guidance for the first quarter and FY25.

Yesterday, the company reported a fourth-quarter FY24 EPS loss of $(0.04), beating the $(0.05) estimate, and sales of $130.96 million exceeded the street view of $124.86 million. 

As of January 31, 2024, total customers increased to 2,044 from 1,770 as of January 31, 2023.

The company held cash and cash equivalents, restricted cash, and marketable securities of $480.0 million as of January 31, 2024.

Outlook: Braze expects first quarter adjusted EPS loss of $(0.11)-$(0.10) vs estimate of $(0.05), revenue of $131 million-$132 million (vs. consensus of $127.82 million).

The company projects FY25 adjusted EPS loss of $(0.12)-$(0.08) vs consensus of $(0.02) and revenue of $570 million-$575 million vs estimate of $572.19 million.

Bill Magnuson, cofounder and CEO said, “Fiscal 2024 marked another significant year for Braze, as we strengthened our position as the leading customer engagement platform and grew revenue by 33%, helping over 2,000 global brands foster growth, loyalty, and retention.”  

Investors can gain exposure to the stock via ProShares Big Data Refiners ETF ( DAT ) and Innovator IBD Breakout Opportunities ETF ( BOUT ) .

Price Action: BRZE shares are down 12.5% at $44.25 on the last check Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
One in four US adults with diabetes used a GLP-1 drug last year, survey finds
One in four US adults with diabetes used a GLP-1 drug last year, survey finds
Aug 13, 2025
By Bhanvi Satija Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly ( LLY ) and Ozempic from Novo Nordisk are...
CK Hutchison's $22.8 billion ports deal in focus as conglomerate reports results
CK Hutchison's $22.8 billion ports deal in focus as conglomerate reports results
Aug 13, 2025
HONG KONG (Reuters) -Investors will look for comments from CK Hutchison ( CKHUF ) on the status of its $22.8 billion ports business sale to a consortium led by U.S. investment firm BlackRock ( BLK ) when the Hong Kong conglomerate reports its results on Thursday. The ports-to-telecoms group will present its interim results at 5 p.m. (0900 GMT), offering...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
CK Hutchison's $22.8 billion ports deal in focus as conglomerate reports results
CK Hutchison's $22.8 billion ports deal in focus as conglomerate reports results
Aug 13, 2025
* Company to hold analyst conference at 5 p.m. * Management expected to be asked about port sale updates * Group raised in July prospect of major Chinese investor joining the bid * H1 underlying profit forecast to rise 6%, UBS says (Adds CK Hutchison share move in paragraph 10) By Clare Jim HONG KONG, Aug 14 (Reuters) - Investors...
Copyright 2023-2026 - www.financetom.com All Rights Reserved